Cover Image
市場調查報告書

全球出國用疫苗市場:2016∼2020年

Global Travel Vaccines Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 325833
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
全球出國用疫苗市場:2016∼2020年 Global Travel Vaccines Market 2016-2020
出版日期: 2016年11月24日 內容資訊: 英文 60 Pages
簡介

在世界朝向全球化之中,出國持續增加。疫苗作為對感染疾病的預防措施廣泛使用,要求出國者遵從每個地區的疫苗接種計劃。全球出國用疫苗市場,預計2016∼2020年以6.83%的年複合成長率擴大。

本報告提供全球出國用疫苗市場相關調查,市場趨勢與課題,各地區趨勢,及加入此市場的主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 疫苗的法律規章方案

第6章 市場情況

  • 市場概要
  • 波特的五力分析

第7章 各疾病類型市場區隔

第8章 各組成市場區隔

  • 單一疫苗
  • 混合疫苗

第9章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

  • 出國者的需求增加
  • 附加的年齡族群核准
  • NIP的引進

第11章 促進要素的影響

第12章 市場課題

  • 指定的保存、流通系統是必須的
  • 疫苗開發伴隨的高風險與成本
  • 嚴格的法律規章指南

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • 其他值得注意的供應商

第16章 主要供應商分析

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

第17章 附錄

第18章 關於Technavio

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR10903

About Travel Vaccines

As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks.

Technavio's analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • Abbott
  • AstraZeneca
  • Bavarian Nordic
  • Baxter
  • Beijing Minhai Biotechnology
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • Bio-Med
  • Seqirus CSL
  • Crucell
  • CSL
  • Dynavax Technologies
  • Emergent BioSolutions
  • GlycoVaxyn
  • GreenSignal Bio Pharma
  • Hualan Biological Engineering
  • Imunoloski Zavod
  • Indian Immunologicals
  • Janssen Pharmaceuticals
  • JN International Medical
  • Kaketsuken
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Novavax
  • Nuron Biotech
  • Panacea Biotec
  • Pfizer
  • Protein Sciences
  • Roche
  • SK Chemicals
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • Takeda Pharmaceutical
  • Vacunas Finlay
  • Valeant Pharmaceuticals
  • Valneva,
  • Zydus Cadila

Market driver

  • Growing demand among travelers
  • For a full, detailed list, view our report

Market challenge

  • Requires specific storage and distribution system
  • For a full, detailed list, view our report

Market trend

  • Combination vaccines
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Regulatory scenario of vaccines

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by disease type

PART 08: Market segmentation by composition

  • Mono vaccines
  • Combination vaccines

PART 09: Geographical segmentation

  • Travel vaccines market in Americas
  • Travel vaccines market in EMEA
  • Travel vaccines market in APAC

PART 10: Market drivers

  • Growing demand among travelers
  • Additional age group approval
  • Inclusion in NIP

PART 11: Impact of drivers

PART 12: Market challenges

  • Requires specific storage and distribution system
  • High risk and cost involved in vaccine development
  • Stringent regulatory guidelines

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Combination vaccines
  • Increase in R&D activities
  • Public-private initiatives

PART 15: Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 16: Key vendor analysis

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Market share of travel vaccines markets in global pharmaceutical market 2015
  • Exhibit 03: Market share of travel vaccines markets in global pharmaceutical market, 2015
  • Exhibit 04: Country/region-specific vaccination
  • Exhibit 05: Key buying criteria for travel vaccines 2015
  • Exhibit 06: Impact of key customer segments on market 2015
  • Exhibit 07: Requirements for a BLA submission
  • Exhibit 08: Stages of vaccine development to obtain license
  • Exhibit 09: Processes involved in the vaccine development
  • Exhibit 10: Regulatory testing of licensed vaccines
  • Exhibit 11: Market snapshot: Global travel vaccines market
  • Exhibit 12: Worldwide endemicity of HAV infection
  • Exhibit 13: Endemicity pattern of HBV across various regions
  • Exhibit 14: Global travel vaccine market snapshot: Developed and emerging markets 2015
  • Exhibit 15: Overview of vaccine-related acquisitions (2005-2012)
  • Exhibit 16: Global travel vaccines market 2015-2020 ($ billions)
  • Exhibit 17: Few of approved travel vaccines
  • Exhibit 18: Vaccine recommendation for travelers
  • Exhibit 19: Five forces analysis
  • Exhibit 20: Market segmentation of travel vaccines based on disease type 2015
  • Exhibit 21: Market share of the different types of travel vaccines based on disease type 2015
  • Exhibit 22: Overview of global travel vaccines market segmentation based on disease type 2015-2020
  • Exhibit 23: Global travel vaccines market segmentation by composition
  • Exhibit 24: Details of approved polysaccharide vaccines
  • Exhibit 25: Snapshot of global travel vaccines market by geography 2015-2020
  • Exhibit 26: Global travel vaccines market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 27: Overview of travel vaccines market in Americas
  • Exhibit 28: Recommended vaccination for travelers to Mexico
  • Exhibit 29: Recommended vaccination for travelers to Brazil
  • Exhibit 30: Travel vaccines market in Americas 2015-2020 ($ billions)
  • Exhibit 31: Overview of travel vaccines market in EMEA
  • Exhibit 32: Outbreaks of measles in EMEA during 2011
  • Exhibit 33: Recommended vaccination for travelers to Italy
  • Exhibit 34: Recommended vaccinations for travelers to France
  • Exhibit 35: Recommended vaccinations for some travelers to South Africa
  • Exhibit 36: Travel vaccines market in EMEA 2015-2020 ($ millions)
  • Exhibit 37: Overview of travel vaccines market in APAC
  • Exhibit 38: Recommended vaccination for travelers to India
  • Exhibit 39: Recommended vaccination for travelers to China
  • Exhibit 40: Travel vaccines market in APAC 2015-2020 ($ millions)
  • Exhibit 41: Impact of drivers and challenges on global travel vaccines market
  • Exhibit 42: Impact of drivers
  • Exhibit 43: A typical cold chain process
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Impact of trends on global travel vaccines market
  • Exhibit 46: Competitive structure analysis of global travel vaccines market 2015
  • Exhibit 47: Key vendors: Geographical presence 2015
  • Exhibit 48: Competitive assessment of vendors
  • Exhibit 49: GlaxoSmithKline: Key highlights
  • Exhibit 50: GlaxoSmithKline: Strength assessment
  • Exhibit 51: GlaxoSmithKline: Strategy assessment
  • Exhibit 52: GlaxoSmithKline: Opportunity assessment
  • Exhibit 53: Merck: Key highlights
  • Exhibit 54: Merck: Strength assessment
  • Exhibit 55: Merck: Strategy assessment
  • Exhibit 56: Merck: Opportunity assessment
  • Exhibit 57: Pfizer: Key highlights
  • Exhibit 58: Pfizer: Strength assessment
  • Exhibit 59: Pfizer: Strategy assessment
  • Exhibit 60: Pfizer: Opportunity assessment
  • Exhibit 61: Sanofi: Key highlights
  • Exhibit 62: Sanofi: Strength assessment
  • Exhibit 63: Sanofi: Strategy assessment
  • Exhibit 64: Sanofi: Opportunity assessment
Back to Top